Literature DB >> 29907926

Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.

Mehrak Javadi-Paydar1, Jacques D Nguyen1, Tony M Kerr1, Yanabel Grant1, Sophia A Vandewater1, Maury Cole2, Michael A Taffe3.   

Abstract

RATIONALE: Previous studies report sex differences in some, but not all, responses to cannabinoids in rats. The majority of studies use parenteral injection; however, most human use is via smoke inhalation and, increasingly, vapor inhalation.
OBJECTIVES: To compare thermoregulatory and locomotor responses to inhaled ∆9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination using an e-cigarette-based model in male and female rats
METHODS: Male and female Wistar rats were implanted with radiotelemetry devices for the assessment of body temperature and locomotor activity. Animals were then exposed to THC or CBD vapor using a propylene glycol (PG) vehicle. THC dose was adjusted via the concentration in the vehicle (12.5-200 mg/mL) and the CBD (100, 400 mg/mL) dose was also adjusted by varying the inhalation duration (10-40 min). Anti-nociception was evaluated using a tail-withdrawal assay following vapor inhalation. Plasma samples obtained following inhalation in different groups of rats were compared for THC content.
RESULTS: THC inhalation reduced body temperature and increased tail-withdrawal latency in both sexes equivalently and in a concentration-dependent manner. Female temperature, activity, and tail-withdrawal responses to THC did not differ between estrus and diestrus. CBD inhalation alone induced modest hypothermia and suppressed locomotor activity in both males and females. Co-administration of THC with CBD, in a 1:4 ratio, significantly decreased temperature and activity in an approximately additive manner and to similar extent in each sex. Plasma THC varied with the concentration in the PG vehicle but did not differ across rat sex.
CONCLUSION: In summary, the inhalation of THC or CBD, alone and in combination, produces approximately equivalent effects in male and female rats. This confirms the efficacy of the e-cigarette-based method of THC delivery in female rats.

Entities:  

Keywords:  Cannabidiol; Hypothermia; Locomotor activity; Sex differences; e-cigarette

Mesh:

Substances:

Year:  2018        PMID: 29907926      PMCID: PMC6699758          DOI: 10.1007/s00213-018-4946-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.

Authors:  Jenny L Wiley; Mary M O'connell; Mary E Tokarz; M Jerry Wright
Journal:  J Pharmacol Exp Ther       Date:  2006-12-15       Impact factor: 4.030

2.  The pharmacological activity of inhalation exposure to marijuana smoke in mice.

Authors:  A H Lichtman; J L Poklis; A Poklis; D M Wilson; B R Martin
Journal:  Drug Alcohol Depend       Date:  2001-07-01       Impact factor: 4.492

3.  Sex differences in antinociceptive and motoric effects of cannabinoids.

Authors:  A H Tseng; R M Craft
Journal:  Eur J Pharmacol       Date:  2001-10-26       Impact factor: 4.432

4.  Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.

Authors:  Eva M Romero; Beatriz Fernández; Onintza Sagredo; Nuria Gomez; Leyre Urigüen; Carmen Guaza; Rosario De Miguel; Jose Antonio Ramos; M Paz Viveros
Journal:  Brain Res Dev Brain Res       Date:  2002-06-30

5.  Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.

Authors:  Kazuhide Hayakawa; Kenichi Mishima; Mai Hazekawa; Kazunori Sano; Keiichi Irie; Kensuke Orito; Takashi Egawa; Yoshihisa Kitamura; Naoki Uchida; Ryoji Nishimura; Nobuaki Egashira; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

6.  Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Authors:  D R Compton; K C Rice; B R De Costa; R K Razdan; L S Melvin; M R Johnson; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

7.  Sex differences in the cannabinoid modulation of appetite, body temperature and neurotransmission at POMC synapses.

Authors:  Shanna Diaz; Borzoo Farhang; Joshua Hoien; Megan Stahlman; Nadira Adatia; Jeremy M Cox; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2009-01-09       Impact factor: 4.914

8.  Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.

Authors:  M Jerry Wright; Sophia A Vandewater; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.

Authors:  Jacques D Nguyen; Shawn M Aarde; Sophia A Vandewater; Yanabel Grant; David G Stouffer; Loren H Parsons; Maury Cole; Michael A Taffe
Journal:  Neuropharmacology       Date:  2016-05-30       Impact factor: 5.250

10.  High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration.

Authors:  Shawn M Aarde; Pai-Kai Huang; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2017-10-17       Impact factor: 3.533

View more
  29 in total

1.  Nicotine e-cigarette vapor inhalation effects on nicotine & cotinine plasma levels and somatic withdrawal signs in adult male Wistar rats.

Authors:  Christian Montanari; Leslie K Kelley; Tony M Kerr; Maury Cole; Nicholas W Gilpin
Journal:  Psychopharmacology (Berl)       Date:  2019-11-23       Impact factor: 4.530

Review 2.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems.

Authors:  Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski
Journal:  J Neurosci Methods       Date:  2019-10-12       Impact factor: 2.390

3.  Female rats self-administer heroin by vapor inhalation.

Authors:  Arnold Gutierrez; Jacques D Nguyen; Kevin M Creehan; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2020-10-24       Impact factor: 3.533

Review 4.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

5.  Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.

Authors:  Jacques D Nguyen; Yanabel Grant; Kevin M Creehan; Candy S Hwang; Sophia A Vandewater; Kim D Janda; Maury Cole; Michael A Taffe
Journal:  Neuropharmacology       Date:  2019-04-11       Impact factor: 5.250

6.  Effects of nicotine and THC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male rats.

Authors:  Mehrak Javadi-Paydar; Tony M Kerr; Eric L Harvey; Maury Cole; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2019-02-27       Impact factor: 4.492

7.  Vapor inhalation of cannabidiol (CBD) in rats.

Authors:  Mehrak Javadi-Paydar; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2019-07-20       Impact factor: 3.533

8.  Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice.

Authors:  Jenny L Wiley; Timothy W Lefever; Michelle Glass; Brian F Thomas
Journal:  Neurotoxicology       Date:  2019-04-03       Impact factor: 4.294

9.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.

Authors:  Jacques D Nguyen; Yanabel Grant; Tony M Kerr; Arnold Gutierrez; Maury Cole; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2018-07-19       Impact factor: 3.533

10.  Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats.

Authors:  Jacques D Nguyen; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.